Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06078735 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study

StatusRecruiting
PhaseNot applicable
Started2023-10-02
View on ClinicalTrials.gov ↗
Record status
This record was last updated October 29, 2024 (before its estimated December 2024 completion). Its status may not reflect the trial's current state.
The LockeT II study is a single center, prospective randomized study. It is intended to study the effectiveness of using LockeT device to gain hemostasis after venous procedures as compared to Manual Compression (MC). Approximately 110 patients will be enrolled.

Amendment record

Amended once since 2023-10-03. Every amendment is listed below.

Dates here are the day the sponsor filed the amendment, not the day ClinicalTrials.gov published it. Version history last read from ClinicalTrials.gov on 2026-08-30.

2024-10-25
Amendment Study Status v1
2023-10-03
Original filing
Trial Details
NCT Number NCT06078735
Lead Sponsor Kansas City Heart Rhythm Research Foundation
Conditions Atrial Fibrillation, Hemostasis
Enrollment 110 participants
Start Date 2023-10-02
Primary Completion 2024-12 (estimated)
Study Completion 2024-12 (estimated)
Updated on ClinicalTrials.gov 2024-10-29